Applied Genetic Technologies Corp. (AGTC) NASDAQ
$0.39 0 (1.23%)
Market Cap: -
As of 11/30/22 04:00 PM EST. Market closed.
Applied Genetic Technologies Corp. (AGTC)
NASDAQ
$0.39
0 (1.23%)
Market Cap: -
As of 11/30/22 04:00 PM EST. Market closed.
Applied Genetic Technologies Corp. (AGTC) is a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthalmic, otologic and central nervous system (CNS) diseases. AGTC is a leader in designing and constructing all critical gene therapy elements and bringing them together to develop customized therapies that address real patient needs. AGTC's ... read more
Applied Genetic Technologies Corp. (AGTC) is a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthalmic, otologic and central nervous system (CNS) diseases. AGTC is a leader in designing and constructing all critical gene therapy elements and bringing them together to develop customized therapies that address real patient needs. AGTC's most advanced clinical programs leverage its best-in-class technology platform to potentially improve vision for patients with an inherited retinal disease. AGTC has active clinical trials in X-linked retinitis pigmentosa (XLRP) and achromatopsia (ACHM CNGB3 and ACHM CNGA3). Its preclinical programs build on the Company's industry leading AAV manufacturing technology and scientific expertise. AGTC is advancing multiple important pipeline candidates to address substantial unmet clinical need in optogenetics, otology and CNS disorders. In recent years AGTC has entered into strategic partnerships with companies including Otonomy, a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, and Bionic Sight, an innovator in the emerging field of optogenetics and retinal coding. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Potter Stephen W | Chief Business Officer | Jul 01, 2022 | Sale | $0.77 | 8,070 | 6,250 | 55,883 | Jul 01, 2022, 04:01 PM |
Reynolds Gerald Anthony | Chief Accounting Officer | May 27, 2022 | Sale | $0.85 | 3,994 | 3,376 | 21,006 | May 31, 2022, 04:24 PM |
Washer Susan B. | President and CEO | Feb 18, 2022 | Option Exercise | $0.35 | 120,686 | 42,240 | 152,971 | Feb 22, 2022, 09:34 PM |
Washer Susan B. | President and CEO | Feb 18, 2022 | Sale | $2.18 | 9,950 | 21,691 | 143,021 | Feb 22, 2022, 09:34 PM |
Washer Susan B. | President and CEO | Nov 01, 2021 | Option Exercise | $3.50 | 3,877 | 13,570 | 32,285 | Nov 03, 2021, 07:19 PM |
Potter Stephen W | Chief Business Officer | Aug 15, 2021 | Option Exercise | $3.58 | 5,724 | 20,492 | 63,953 | Aug 17, 2021, 06:42 PM |
Potter Stephen W | VP and Chief Business Officer | Aug 15, 2020 | Option Exercise | $5.77 | 5,723 | 33,022 | 34,677 | Aug 18, 2020, 06:22 PM |
Shearman Mark S | Chief Scientific Officer | Aug 15, 2020 | Option Exercise | $5.77 | 5,723 | 33,022 | 33,277 | Aug 18, 2020, 06:15 PM |
Krol Patrick Johan Hendrik | 10% Owner | Dec 26, 2019 | Sale | $5.24 | 81,162 | 425,289 | 1,780,762 | Dec 30, 2019, 04:33 PM |
Krol Patrick Johan Hendrik | 10% Owner | Nov 19, 2019 | Buy | $2.79 | 2,544 | 7,098 | 1,861,924 | Nov 26, 2019, 05:17 PM |
Washer Susan B. | President and CEO | Sep 18, 2019 | Option Exercise | $3.50 | 5,700 | 19,950 | 28,408 | Sep 20, 2019, 04:22 PM |
Feinsod Matthew | Interim Chief Medical Officer | Jul 11, 2019 | Option Exercise | $3.75 | 592 | 2,220 | 56,052 | Jul 15, 2019, 04:45 PM |
Feinsod Matthew | Interim Chief Medical Officer | Jun 11, 2019 | Option Exercise | $3.70 | 685 | 2,535 | 54,644 | Jun 20, 2019, 04:39 PM |
Feinsod Matthew | Interim Chief Medical Officer | Jun 11, 2019 | Option Exercise | $3.77 | 685 | 2,582 | 54,644 | Jun 13, 2019, 07:21 PM |
Koenig Scott | Director | May 28, 2019 | Option Exercise | $0.35 | 32,018 | 11,206 | 34,246 | May 30, 2019, 04:04 PM |
Feinsod Matthew | Interim Chief Medical Officer | May 13, 2019 | Option Exercise | $4.06 | 685 | 2,781 | 53,329 | May 20, 2019, 04:02 PM |
Feinsod Matthew | Interim Chief Medical Officer | May 13, 2019 | Option Exercise | $4.20 | 685 | 2,877 | 53,329 | May 15, 2019, 04:21 PM |
Feinsod Matthew | Interim Chief Medical Officer | Apr 11, 2019 | Option Exercise | $4.61 | 606 | 2,794 | 52,014 | Apr 15, 2019, 05:42 PM |
Feinsod Matthew | Interim Chief Medical Officer | Mar 11, 2019 | Option Exercise | $3.97 | 667 | 2,648 | 50,620 | Mar 13, 2019, 05:16 PM |
Feinsod Matthew | Interim Chief Medical Officer | Feb 11, 2019 | Option Exercise | $3.29 | 791 | 2,602 | 49,287 | Feb 13, 2019, 06:30 PM |
Feinsod Matthew | Interim Chief Medical Officer | Jan 11, 2019 | Option Exercise | $3.20 | 713 | 2,282 | 48,078 | Jan 15, 2019, 07:58 PM |
Rosen James | Director | Dec 14, 2018 | Buy | $3.38 | 1,000 | 3,381 | 1,000 | Dec 18, 2018, 08:29 PM |
Aliski William | Director | Dec 14, 2018 | Buy | $3.25 | 6,000 | 19,477 | 8,500 | Dec 18, 2018, 08:20 PM |
Sullivan William A. | Chief Financial Officer | Dec 14, 2018 | Buy | $3.33 | 3,000 | 9,990 | 3,000 | Dec 18, 2018, 08:10 PM |
Shearman Mark S | Chief Scientific Officer | Dec 14, 2018 | Sale | $3.35 | 3,000 | 10,053 | 0 | Dec 18, 2018, 07:58 PM |
Washer Susan B. | President and CEO | Dec 14, 2018 | Buy | $3.34 | 2,380 | 7,949 | 22,708 | Dec 18, 2018, 07:36 PM |
Feinsod Matthew | Interim Chief Medical Officer | Dec 11, 2018 | Option Exercise | $6.11 | 611 | 3,733 | 46,791 | Dec 13, 2018, 09:23 PM |
Feinsod Matthew | Interim Chief Medical Officer | Nov 12, 2018 | Option Exercise | $7.05 | 685 | 4,829 | 45,402 | Nov 14, 2018, 04:43 PM |
Feinsod Matthew | Interim Chief Medical Officer | Oct 11, 2018 | Option Exercise | $6.46 | 612 | 3,954 | 44,087 | Oct 15, 2018, 07:01 PM |
Feinsod Matthew | Interim Chief Medical Officer | Sep 11, 2018 | Option Exercise | $3.92 | 685 | 2,689 | 42,699 | Sep 13, 2018, 05:04 PM |
Feinsod Matthew | Interim Chief Medical Officer | Aug 13, 2018 | Option Exercise | $4.00 | 592 | 2,368 | 41,384 | Aug 15, 2018, 07:07 PM |
Feinsod Matthew | Interim Chief Medical Officer | Jul 11, 2018 | Option Exercise | $4.15 | 685 | 2,843 | 39,976 | Jul 13, 2018, 05:57 PM |
Feinsod Matthew | Interim Chief Medical Officer | Jun 11, 2018 | Option Exercise | $4.55 | 606 | 2,757 | 38,661 | Jun 13, 2018, 07:33 PM |
Feinsod Matthew | Interim Chief Medical Officer | May 16, 2018 | Option Exercise | $5.60 | 3,425 | 19,180 | 37,267 | May 18, 2018, 06:17 PM |
Feinsod Matthew | Interim Chief Medical Officer | May 11, 2018 | Option Exercise | $4.90 | 685 | 3,357 | 40,692 | May 15, 2018, 04:34 PM |
Feinsod Matthew | Interim Chief Medical Officer | Apr 11, 2018 | Option Exercise | $4.00 | 685 | 2,740 | 39,377 | Apr 13, 2018, 04:20 PM |
Feinsod Matthew | Interim Chief Medical Officer | Feb 09, 2018 | Option Exercise | $3.95 | 733 | 2,895 | 26,729 | Apr 06, 2018, 08:45 PM |
Feinsod Matthew | Interim Chief Medical Officer | Jan 11, 2018 | Option Exercise | $4.30 | 791 | 3,401 | 25,462 | Apr 06, 2018, 08:26 PM |
Feinsod Matthew | Interim Chief Medical Officer | Dec 11, 2017 | Option Exercise | $3.75 | 3,395 | 12,731 | 24,253 | Apr 06, 2018, 08:15 PM |
Feinsod Matthew | Interim Chief Medical Officer | Mar 12, 2018 | Option Exercise | $4.30 | 667 | 2,868 | 32,126 | Mar 14, 2018, 07:49 PM |
Feinsod Matthew | Interim Chief Medical Officer | Jan 11, 2018 | Option Exercise | $4.30 | 855 | 3,677 | 28,793 | Jan 16, 2018, 08:29 PM |
Magovcevic Ivana | Director | Nov 16, 2016 | Buy | $9.63 | 3,000 | 28,875 | 3,000 | Nov 17, 2016, 04:53 PM |
Chulay Jeffrey D. | VP and Chief Medical Officer | Nov 01, 2016 | Sale | $7.05 | 1,000 | 7,051 | 20,400 | Nov 02, 2016, 06:42 PM |
Chulay Jeffrey D. | VP and Chief Medical Officer | Oct 19, 2016 | Option Exercise | $0.35 | 10,000 | 3,500 | 21,400 | Oct 27, 2016, 08:24 PM |
Chulay Jeffrey D. | VP and Chief Medical Officer | Oct 19, 2016 | Option Exercise | $0.35 | 1,000 | 350 | 12,400 | Oct 21, 2016, 06:03 PM |
Potter Stephen W | See Remarks | Sep 20, 2016 | Buy | $8.69 | 400 | 3,476 | 1,400 | Sep 27, 2016, 05:12 PM |
Potter Stephen W | See Remarks | Sep 16, 2016 | Buy | $8.97 | 1,000 | 8,970 | 1,000 | Sep 27, 2016, 05:12 PM |
Shearman Mark S | Chief Scientific Officer | Sep 22, 2016 | Buy | $8.87 | 3,000 | 26,601 | 3,000 | Sep 26, 2016, 05:20 PM |
BULLOCK LAWRENCE E | Chief Financial Officer | Sep 19, 2016 | Buy | $8.75 | 10,000 | 87,500 | 10,000 | Sep 20, 2016, 04:51 PM |
Washer Susan B. | See Remarks | Aug 29, 2016 | Option Exercise | $3.50 | 5,328 | 18,648 | 20,328 | Aug 30, 2016, 05:43 PM |
Chulay Jeffrey D. | VP and Chief Medical Officer | May 25, 2016 | Option Exercise | $3.50 | 2,000 | 7,000 | 11,900 | May 26, 2016, 07:03 PM |
Chulay Jeffrey D. | VP and Chief Medical Officer | May 11, 2016 | Option Exercise | $3.50 | 4,000 | 14,000 | 9,900 | May 26, 2016, 07:00 PM |
GLAXOSMITHKLINE PLC | Former 10% Owner | Feb 23, 2015 | Sale | $22.00 | 503,150 | 11,069,602 | 1,436,448 | Feb 24, 2015, 04:05 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Dec 10, 2014 | Sale | $21.18 | 10,000 | 211,760 | 1,979,598 | Feb 12, 2015, 06:31 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Dec 18, 2014 | Sale | $21.01 | 12,000 | 252,136 | 1,939,598 | Feb 12, 2015, 06:31 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Dec 17, 2014 | Sale | $21.00 | 8,000 | 168,000 | 1,951,598 | Feb 12, 2015, 06:31 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Dec 12, 2014 | Sale | $21.24 | 7,500 | 159,294 | 1,959,598 | Feb 12, 2015, 06:31 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Dec 11, 2014 | Sale | $21.28 | 12,500 | 266,035 | 1,967,098 | Feb 12, 2015, 06:31 PM |
Menichella Daniel L | V.P. & Chief Business Officer | Jan 23, 2015 | Option Exercise | $4.90 | 1,996 | 9,780 | 1,996 | Jan 26, 2015, 06:04 PM |
Menichella Daniel L | V.P. & Chief Business Officer | Jan 23, 2015 | Sale | $24.90 | 1,996 | 49,700 | 0 | Jan 26, 2015, 06:04 PM |
Menichella Daniel L | V.P. & Chief Business Officer | Dec 22, 2014 | Option Exercise | $4.90 | 9,000 | 44,100 | 9,000 | Dec 23, 2014, 02:54 PM |
Menichella Daniel L | V.P. & Chief Business Officer | Dec 22, 2014 | Sale | $20.83 | 9,000 | 187,470 | 0 | Dec 23, 2014, 02:54 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Apr 01, 2014 | Buy | $12.00 | 103,762 | 1,245,144 | 1,989,598 | Apr 02, 2014, 12:42 PM |
Wu Samuel | Director | Apr 01, 2014 | Buy | $12.00 | 75,735 | 908,820 | 1,452,196 | Apr 01, 2014, 04:31 PM |
Rosen James | Director | Apr 01, 2014 | Buy | $12.00 | 62,871 | 754,452 | 1,205,537 | Apr 01, 2014, 04:31 PM |
ORONSKY ARNOLD L | Director | Apr 01, 2014 | Buy | $12.00 | 75,736 | 908,832 | 1,452,216 | Apr 01, 2014, 04:30 PM |
MedImmune Ventures, Inc. | 10% Owner | Apr 01, 2014 | Buy | $12.00 | 75,735 | 908,820 | 1,452,196 | Apr 01, 2014, 04:29 PM |
Carroll Jill | Director | Apr 01, 2014 | Buy | $12.00 | 103,762 | 1,245,144 | 1,989,598 | Apr 01, 2014, 04:29 PM |
Alta Partners VIII, L.P. | 10% Owner | Apr 01, 2014 | Buy | $12.00 | 155,645 | 1,867,740 | 2,984,400 | Apr 01, 2014, 04:28 PM |
INTERWEST PARTNERS VIII LP | 10% Owner | Apr 01, 2014 | Buy | $12.00 | 75,376 | 904,512 | 1,452,216 | Apr 01, 2014, 02:06 PM |
Owner | Relationship | Date | Value($) |
Potter Stephen W | Chief Business Officer | 07/01/2022 | 6,250 |
Reynolds Gerald Anthony | Chief Accounting Officer | 05/27/2022 | 3,376 |
Washer Susan B. | President and CEO | 02/18/2022 | 42,240 |
Washer Susan B. | President and CEO | 02/18/2022 | 21,691 |
Washer Susan B. | President and CEO | 11/01/2021 | 13,570 |
Potter Stephen W | Chief Business Officer | 08/15/2021 | 20,492 |
Potter Stephen W | VP and Chief Business Officer | 08/15/2020 | 33,022 |
Shearman Mark S | Chief Scientific Officer | 08/15/2020 | 33,022 |
Krol Patrick Johan Hendrik | 10% Owner | 12/26/2019 | 425,289 |
Krol Patrick Johan Hendrik | 10% Owner | 11/19/2019 | 7,098 |
Washer Susan B. | President and CEO | 09/18/2019 | 19,950 |
Feinsod Matthew | Interim Chief Medical Officer | 07/11/2019 | 2,220 |
Feinsod Matthew | Interim Chief Medical Officer | 06/11/2019 | 2,535 |
Feinsod Matthew | Interim Chief Medical Officer | 06/11/2019 | 2,582 |
Koenig Scott | Director | 05/28/2019 | 11,206 |
Feinsod Matthew | Interim Chief Medical Officer | 05/13/2019 | 2,781 |
Feinsod Matthew | Interim Chief Medical Officer | 05/13/2019 | 2,877 |
Feinsod Matthew | Interim Chief Medical Officer | 04/11/2019 | 2,794 |
Feinsod Matthew | Interim Chief Medical Officer | 03/11/2019 | 2,648 |
Feinsod Matthew | Interim Chief Medical Officer | 02/11/2019 | 2,602 |
Feinsod Matthew | Interim Chief Medical Officer | 01/11/2019 | 2,282 |
Rosen James | Director | 12/14/2018 | 3,381 |
Aliski William | Director | 12/14/2018 | 19,477 |
Sullivan William A. | Chief Financial Officer | 12/14/2018 | 9,990 |
Shearman Mark S | Chief Scientific Officer | 12/14/2018 | 10,053 |
Washer Susan B. | President and CEO | 12/14/2018 | 7,949 |
Feinsod Matthew | Interim Chief Medical Officer | 12/11/2018 | 3,733 |
Feinsod Matthew | Interim Chief Medical Officer | 11/12/2018 | 4,829 |
Feinsod Matthew | Interim Chief Medical Officer | 10/11/2018 | 3,954 |
Feinsod Matthew | Interim Chief Medical Officer | 09/11/2018 | 2,689 |
Feinsod Matthew | Interim Chief Medical Officer | 08/13/2018 | 2,368 |
Feinsod Matthew | Interim Chief Medical Officer | 07/11/2018 | 2,843 |
Feinsod Matthew | Interim Chief Medical Officer | 06/11/2018 | 2,757 |
Feinsod Matthew | Interim Chief Medical Officer | 05/16/2018 | 19,180 |
Feinsod Matthew | Interim Chief Medical Officer | 05/11/2018 | 3,357 |
Feinsod Matthew | Interim Chief Medical Officer | 04/11/2018 | 2,740 |
Feinsod Matthew | Interim Chief Medical Officer | 02/09/2018 | 2,895 |
Feinsod Matthew | Interim Chief Medical Officer | 01/11/2018 | 3,401 |
Feinsod Matthew | Interim Chief Medical Officer | 12/11/2017 | 12,731 |
Feinsod Matthew | Interim Chief Medical Officer | 03/12/2018 | 2,868 |
Feinsod Matthew | Interim Chief Medical Officer | 01/11/2018 | 3,677 |
Magovcevic Ivana | Director | 11/16/2016 | 28,875 |
Chulay Jeffrey D. | VP and Chief Medical Officer | 11/01/2016 | 7,051 |
Chulay Jeffrey D. | VP and Chief Medical Officer | 10/19/2016 | 3,500 |
Chulay Jeffrey D. | VP and Chief Medical Officer | 10/19/2016 | 350 |
Potter Stephen W | See Remarks | 09/20/2016 | 3,476 |
Potter Stephen W | See Remarks | 09/16/2016 | 8,970 |
Shearman Mark S | Chief Scientific Officer | 09/22/2016 | 26,601 |
BULLOCK LAWRENCE E | Chief Financial Officer | 09/19/2016 | 87,500 |
Washer Susan B. | See Remarks | 08/29/2016 | 18,648 |
Chulay Jeffrey D. | VP and Chief Medical Officer | 05/25/2016 | 7,000 |
Chulay Jeffrey D. | VP and Chief Medical Officer | 05/11/2016 | 14,000 |
GLAXOSMITHKLINE PLC | Former 10% Owner | 02/23/2015 | 11,069,602 |
GLAXOSMITHKLINE PLC | 10% Owner | 12/10/2014 | 211,760 |
GLAXOSMITHKLINE PLC | 10% Owner | 12/18/2014 | 252,136 |
GLAXOSMITHKLINE PLC | 10% Owner | 12/17/2014 | 168,000 |
GLAXOSMITHKLINE PLC | 10% Owner | 12/12/2014 | 159,294 |
GLAXOSMITHKLINE PLC | 10% Owner | 12/11/2014 | 266,035 |
Menichella Daniel L | V.P. & Chief Business Officer | 01/23/2015 | 9,780 |
Menichella Daniel L | V.P. & Chief Business Officer | 01/23/2015 | 49,700 |
Menichella Daniel L | V.P. & Chief Business Officer | 12/22/2014 | 44,100 |
Menichella Daniel L | V.P. & Chief Business Officer | 12/22/2014 | 187,470 |
GLAXOSMITHKLINE PLC | 10% Owner | 04/01/2014 | 1,245,144 |
Wu Samuel | Director | 04/01/2014 | 908,820 |
Rosen James | Director | 04/01/2014 | 754,452 |
ORONSKY ARNOLD L | Director | 04/01/2014 | 908,832 |
MedImmune Ventures, Inc. | 10% Owner | 04/01/2014 | 908,820 |
Carroll Jill | Director | 04/01/2014 | 1,245,144 |
Alta Partners VIII, L.P. | 10% Owner | 04/01/2014 | 1,867,740 |
INTERWEST PARTNERS VIII LP | 10% Owner | 04/01/2014 | 904,512 |